Drugs / Tdap
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01367158 | Jul 2011 → Jan 2012 | meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tdap | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01367158 ↗ |
| Modality | Vaccine | “Sterile liquid suspension of tetanus and diphtheria toxoids and acellular pertussis components intended for intramuscular injection” NCT01367158 ↗ |
| Route | Intramuscular | “intended for intramuscular injection” NCT01367158 ↗ |